Effect of high-dose aspirin on Helicobacter pylori eradication

Digestive Diseases and Sciences

Volumn 50, Issue 4, 2005, Pages 626-629

  Park, Seung Ha ^a   Park, Dong Il ^a,b   Kim, Sang Hoon ^a   Kim, Hong Joo ^a   Cho, Yong Kyun ^a   Sung, In Kyung ^a   Sohn, Chong Il ^a   Jeon, Woo Kyu ^a   Kim, Byung Ik ^a   Keum, Dong Keuk ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b NONE   (South Korea)

Author keywords

Aspirin; Eradication; Helicobacter pylori; Peptic ulcer

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ARTICLE; BACTERIAL INFECTION; BLEEDING; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ENDOSCOPY; ERADICATION THERAPY; FEMALE; FOLLOW UP; HEADACHE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PEPTIC ULCER; PILOT STUDY; PRIORITY JOURNAL; TASTE DISORDER;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ASPIRIN; CHRONIC DISEASE; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PILOT PROJECTS;

EID: 20244370506     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2547-3     Document Type: Article

References (17)

1. Hunt RH: Eradication of Helicobacter pylori infection. Am J Med 100(5A):S42-S50, 1996
2. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. J Am Med Assoc 272:65-69, 1994
3. Ulmer HJ, Beckerling A, Gatz G: Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review. Helicobacter 8:95-104, 2003
4. Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY: Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 161:1217-1220, 2001
5. Meyer JM, Silliman NP, Wang W, Siepman NY, Sugg JE, Morris D, Zhang J, Bhattacharyya H, King EC, Hopkins RJ: Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann Intern Med 136:13-24, 2002
6. Caselli M, Pazzi P, LaCorte R, Aleotti A, Trevisani L, Stabellini G: Campylobacter-like organisms, nonsteroidal anti-inflammatory drugs and gastric lesions in patients with rheumatoid arthritis. Digestion 44:101-104, 1989
7. Wang WH, Wong WM, Dailidiene D, Berg DE, Gu Q, Lai KC, Lam SK, Wong BC: Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents. Gut 52:490-495, 2003
8. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161-1181, 1996
9. Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M, Weinstein WM: Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial. Aliment Pharmacol Ther 9:127-135, 1995
10. Konturek JW, Dembinski A, Konturek SJ, Stachura J, Domschke W: Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. Gastroenterology 114:245-255, 1998
11. Cryer B, Feldman M: Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 117:17-25, 1999
12. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ: Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 34:748-751, 1993
13. Konturek SJ, Bielanski W, Plonka M, Pawlik T, Pepera J, Konturek PC, Czarnecki J, Penar A, Jedrychowski W: Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers. Scand J Gastroenterol 38:923-930, 2003
14. Louw JA, van Rensburg CJ, Hanslo D, Grundlings HD, Girdwood AH, Marks IN: Two week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing. Aliment Pharmacol Ther 12:545-550, 1998
15. Maconi G, Parente F, Russo A, Vago L, Imbesi V, Porro GB: Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol 96:359-366, 2001
16. Megraud F, Lehn N, Lind T, Bayerdorffer E, O'Morain C, Spiller R, Unge P, van Zanten SV, Wrangstadh M, Burman CF: Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother 43:2747-2752, 1999
17. Hoshiya S, Watanabe K, Tokunaga K, Tanaka A, Ninomiya H, Shingaki M, Itoh T, Saito S, Ishida H, Takahashi S: Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol 35:10-14, 2000